J&J Could Explore Potential $2B Sale of Sterilization Products Division Post author:Sam Post published:February 19, 2018 Post category:BioPharma Life sciences giant Johnson & Johnson may be shopping around its sterilization products division. Source: BioSpace You Might Also Like 3 FDA Decisions to Look Out for in February January 31, 2018 InfuSystem Holdings, Inc. Announces Amendment To Existing Credit Facility With June 29, 2017 Another Day, Another Breakthrough Tag for GlaxoSmithKline's Bexsero February 6, 2018